OCON Therapeutics

Our mission is to introduce an innovative,
high-quality intrauterine drug-delivery technology
to improve and impact women’s health and quality of life

OCON Healthcare​

Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact  women’s health and quality of life

This Is What We Do

OUR PRODUCTS

why ocon?

Finally, women’s health products that are designed and managed by women for women that fit women’s anatomy and needs.

OCON’s platform technology excels in simplicity, safety, cost-effectiveness, new and innovative technology.

in the media

OCON Therapeutics has reached its recruitment goal of its Phase IIb clinical study evaluating the revolutionary IUB® SEAD®, a non-invasive treatment for heavy menstrual bleeding affecting 1 in 3 women

March 24, 2023

|

Femtechworld

OCON Therapeutics is honored to be part of Bolt PR’s (A Millwright Agency) important list of Femtech Brands and Innovations to watch in 2023

March 15, 2023

|

Boltpr

1 compared to literature of Traditional IUDs and ongoing vigilance reporting for IUB®  BALLERINE®, OCON Medical Ltd.

2 ongoing Phase II Clinical Studies, OCON Medical Ltd.